Veeva Study Startup

Accelerate Study Start-up, Enroll Patients Faster

Eliminate costly delays by bringing together study start-up
activities and processes in one easy-to-use application.

Announced 2015 Status Mature Customers 11-50
Veeva Study Startup
Learn how AstraZeneca saves 260 working days for monitors
Read More
Overview

Efficiently manage
trial start-up activities
with Veeva Study Startup

Download Product Sheet View Features

Manage trial start-up activities

Veeva Study Startup manages feasibility, qualification, and activation of research sites.

Simplify site selection

Feasibility surveys are sent to research sites during the site selection phase. Standard feasibility questions simplify the site experience across studies. Sites are automatically scored based on their response, and those selected are routed into the site activation process.

Drive site activation

Veeva Study Startup drives site activation through standard tasks and milestones. These are controlled through provided and flexible country intelligence templates that specify the processes and documentation required before activating a site.

Get complete visibility

Information is collected, tracked, and presented in dashboard views to deliver visibility of start-up progress and timelines.

Impact

Improve operational efficiency

50%

decrease in average days from site selected to ready for enrollment

45%

faster to enroll the first subject after site initiation

42%

decrease from protocol approved to first subject enrolled

Why Veeva Study Startup

Manage end-to-end processes in one system

Speed study start-up

Streamline feasibility, site selection, budgets and contracts, and site greenlight to execute trials faster.

Enable effective collaboration

Achieve greater alignment across study partners through seamless exchange of trial information that drives better decisions.

Make more informed decisions

Prioritize dependent and at-risk tasks, documents, and milestones through automated critical path management.

Customer Success

Finding and activating the right sites faster

Alexion Bayer BioNTech Boehringer-Ingelheim Ferring Fortrea GSK Novartis Novo-Nordisk Parexel Vertex

"In the last year we saved 260 working days of monitors’ time.”

Anna Wenelska, Veeva Study Startup Product Owner
AstraZeneca
Read more

"We now have a single place to track start-up activities for all global trials, providing visibility and transparency across the organization."

Lorena Gomez, Global Head, Study Start Up,
PRO Management, and Digital Implementation
AbbVie

"Our goal was to eliminate 90% of manual processes. We’re on track to do even better than that."

Dewey Denham, Sr. Director, Global Quality Control
Fortrea
Watch video
Resources

Explore and Learn

Read case study
Learn how AstraZeneca optimizes with data-driven strategies
Watch customer video
Fortrea eliminates manual study start-up processes
Watch video
GSK's unified study start-up journey
Watch video
Know what’s on the critical path with Veeva Study Startup
Read white paper
Leading organizational change through a study start-up transformation
View features brief
Bring together start-up content and data to accelerate time to site activation
Watch video
Improve performance by measuring study start-up cycle times
Read article
Four steps to accelerate study start-up cycles

Interested in learning more?

Contact Us Download Product Sheet